rrd268159_303104.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R5/Tzzwlech7yb8mv7uIo2QChdYIkGSSdlessedL+ACFRaYn/g8UWYkp5zYzEFfO i9Oomx+cQYJ4qgZLPe9r0g== 0001181431-11-006762.txt : 20110202 0001181431-11-006762.hdr.sgml : 20110202 20110202173248 ACCESSION NUMBER: 0001181431-11-006762 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110131 FILED AS OF DATE: 20110202 DATE AS OF CHANGE: 20110202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON JOHN CENTRAL INDEX KEY: 0001410781 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 11567669 MAIL ADDRESS: STREET 1: SAVIENT PHARMACEUTICALS, INC. STREET 2: 14TH FLOOR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER NAME: FORMER CONFORMED NAME: Johnson John H DATE OF NAME CHANGE: 20070827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd299205.xml JOHN JOHNSON FORM 3 X0203 3 2011-01-31 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001410781 JOHNSON JOHN SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 1 1 0 0 Chief Executive Officer Common Stock, $.01 par value per share 230000 D Option to Purchase Common Stock, $.01 par value 9.23 2011-01-31 2021-01-31 Common Stock, $.01 par value per share 250000 D The right to receive these shares is pursuant to a restricted stock grant and vest as follows: 50,000 on December 31, 2011, 130,000 on June 30, 2012, 25,000 on December 31, 2012, and 25,000 on December 31, 2013, provided that the grantee remains employed by the Company on these dates. These options will become exercisable as follows: 83,333 shares on January 31, 2012, 83,333 shares on January 31, 2013 and 83,334 shares on January 31, 2014, provided the optionee remains employed by the Company on these dates. /s/ Irina Azer as Attorney-In-Fact for John Johnson 2011-02-02 EX-24.1 2 rrd268159_303104.htm POWER OF ATTORNEY FOR JOHN JOHNSON rrd268159_303104.html

POWER OF ATTORNEY

Know all by these present that the undersigned hereby constitutes and appoints Philip K. Yachmetz and Irina Ishak with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)        execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or employee of Savient Pharmaceuticals, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)        do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)         take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfu lly do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

The undersigned hereby revokes and withdraws any previously executed powers of attorney with respect to the completion, execution and filing of Forms 3, 4 and 5 relating to the undersigned's holdings of and transactions in securities issued by the Company.

IN WITNESS W HEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of February, 2011.

        /s/ John Johnson
        Signature

        John Johnson
        Print Name

-----END PRIVACY-ENHANCED MESSAGE-----